Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 493 views
- Frontiers in Hematology
- Blood Cancer
- Articles
Type at least 3 characters
65 articles
Case Report
Published on 15 Jul 2025
Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1527938
- 326 views
Brief Research Report
Published on 11 Jul 2025
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1613099
- 398 views
Case Report
Published on 23 Jun 2025
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
- 258 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 743 views
Case Report
Published on 18 Jun 2025
Successful management of acute promyelocytic leukemia in the third trimester of pregnancy: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1553336
- 769 views
Original Research
Published on 23 May 2025
Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1479185
- 680 views
Original Research
Published on 14 May 2025
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1557641
- 818 views
Mini Review
Published on 13 May 2025
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
- 504 views
Original Research
Published on 06 May 2025
Disease and treatment burden in patients with leukaemia: family members/partner perspective
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
- 827 views
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 897 views
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 1,359 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 1,030 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 1,195 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 1,047 views
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 689 views